Indonesia
· Delayed Price · Currency is IDR PT Kalbe Farma Tbk. Statistics
Total Valuation
PT Kalbe Farma Tbk. has a market cap or net worth of IDR 66.92 trillion. The enterprise value is 65.07 trillion.
| Market Cap | 66.92T |
| Enterprise Value | 65.07T |
Important Dates
The last earnings date was Wednesday, October 30, 2024.
| Earnings Date | Oct 30, 2024 |
| Ex-Dividend Date | May 29, 2024 |
Share Statistics
PT Kalbe Farma Tbk. has 46.15 billion shares outstanding. The number of shares has decreased by -0.86% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 46.15B |
| Shares Change (YoY) | -0.86% |
| Shares Change (QoQ) | -0.48% |
| Owned by Insiders (%) | 0.25% |
| Owned by Institutions (%) | 13.65% |
| Float | 18.85B |
Valuation Ratios
The trailing PE ratio is 21.71 and the forward PE ratio is 19.12. PT Kalbe Farma Tbk.'s PEG ratio is 1.55.
| PE Ratio | 21.71 |
| Forward PE | 19.12 |
| PS Ratio | 2.08 |
| PB Ratio | 3.02 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 16.75 |
| P/OCF Ratio | n/a |
| PEG Ratio | 1.55 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 13.73, with an EV/FCF ratio of 16.29.
| EV / Earnings | 21.13 |
| EV / Sales | 2.03 |
| EV / EBITDA | 13.73 |
| EV / EBIT | 16.23 |
| EV / FCF | 16.29 |
Financial Position
The company has a current ratio of 4.15, with a Debt / Equity ratio of 0.03.
| Current Ratio | 4.15 |
| Quick Ratio | 2.32 |
| Debt / Equity | 0.03 |
| Debt / EBITDA | 0.16 |
| Debt / FCF | 0.19 |
| Interest Coverage | 70.91 |
Financial Efficiency
Return on equity (ROE) is 13.40% and return on invested capital (ROIC) is 10.36%.
| Return on Equity (ROE) | 13.40% |
| Return on Assets (ROA) | 8.92% |
| Return on Capital (ROIC) | 10.36% |
| Revenue Per Employee | 2.49B |
| Profits Per Employee | 238.33M |
| Employee Count | 13,108 |
| Asset Turnover | 1.15 |
| Inventory Turnover | 2.84 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -8.92% in the last 52 weeks. The beta is 0.21, so PT Kalbe Farma Tbk.'s price volatility has been lower than the market average.
| Beta (5Y) | 0.21 |
| 52-Week Price Change | -8.92% |
| 50-Day Moving Average | 1,643.50 |
| 200-Day Moving Average | 1,566.45 |
| Relative Strength Index (RSI) | 37.04 |
| Average Volume (20 Days) | 32,888,610 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PT Kalbe Farma Tbk. had revenue of IDR 32.13 trillion and earned 3.08 trillion in profits. Earnings per share was 66.79.
| Revenue | 32.13T |
| Gross Profit | 12.21T |
| Operating Income | 3.99T |
| Pretax Income | 4.08T |
| Net Income | 3.08T |
| EBITDA | 4.67T |
| EBIT | 3.99T |
| Earnings Per Share (EPS) | 66.79 |
Balance Sheet
The company has 4.32 trillion in cash and 743.45 billion in debt, giving a net cash position of 3.57 trillion or 77.42 per share.
| Cash & Cash Equivalents | 4.32T |
| Total Debt | 743.45B |
| Net Cash | 3.57T |
| Net Cash Per Share | 77.42 |
| Equity (Book Value) | 23.91T |
| Book Value Per Share | 480.69 |
| Working Capital | 12.93T |
Cash Flow
In the last 12 months, operating cash flow was 4.96 trillion and capital expenditures -962.19 billion, giving a free cash flow of 3.99 trillion.
| Operating Cash Flow | 4.96T |
| Capital Expenditures | -962.19B |
| Free Cash Flow | 3.99T |
| FCF Per Share | 86.54 |
Margins
Gross margin is 38.02%, with operating and profit margins of 12.42% and 9.59%.
| Gross Margin | 38.02% |
| Operating Margin | 12.42% |
| Pretax Margin | 12.71% |
| Profit Margin | 9.59% |
| EBITDA Margin | 14.54% |
| EBIT Margin | 12.42% |
| FCF Margin | 12.43% |
Dividends & Yields
This stock pays an annual dividend of 31.00, which amounts to a dividend yield of 2.12%.
| Dividend Per Share | 31.00 |
| Dividend Yield | 2.12% |
| Dividend Growth (YoY) | -18.42% |
| Years of Dividend Growth | 3 |
| Payout Ratio | 46.55% |
| Buyback Yield | 0.86% |
| Shareholder Yield | 2.98% |
| Earnings Yield | 4.61% |
| FCF Yield | 5.97% |
Stock Splits
The last stock split was on October 8, 2012. It was a forward split with a ratio of 5.
| Last Split Date | Oct 8, 2012 |
| Split Type | Forward |
| Split Ratio | 5 |
Scores
PT Kalbe Farma Tbk. has an Altman Z-Score of 12.31.
| Altman Z-Score | 12.31 |
| Piotroski F-Score | n/a |